INVESTIGATING THE RELATIONSHIP BETWEEN SERUM PENTRAXIN3 LEVEL AND ANGIOGRAPHIC FINDINGS IN PATIENTS WITH CORONARY ANGIOGRAPHY

Abstract

Objective: Pentraxin3 (PTX3) is an inflammatory single-phase mononuclear polysorbate glycoprotein, synthesized by endothelial, macrophages, and mildew cells; based on reports and research findings, it is also believed to be synthesized in the tissue of atherosclerotic lesions of arterial arteries. Therefore, PTX3 can be considered as a more specific marker for atherosclerosis. The present study examines the relationship between PTX3 serum levels and coronary angiography findings.Methods: A total of 100 patients with stable cardiac status under elective coronary angiography were studied. Meanwhile, serum levels of PTX3 were measured, along with coronary angiography, in these patients. Finally, the relationship between the serum level of this marker and the severity of the angiographic findings of these individuals was compared and contrasted.Results: out of 100 patients examined in the present study, 57 subjects (57.6%) were male and 42 subjects (42.4%) were female. The mean age of participants turned out to be 53±9.16, and the mean serum level of PTX3 was 5.91±12.5. The mean serum level of PTX3 turned out to be lower in patients with normal angiography than in those with coronary artery disease (p<0.0001). Smoking and age did not affect the mean serum levels of this marker. Furthermore, a higher serum level of PTX3 was associated with a higher syntax score in the angiography (p<0.0001).Conclusion: Serum levels of PTX3 can have a predictive value in the diagnosis of coronary artery disease in patients with stable cardiovascular symptoms.